SHAREHOLDER ALERT: WeissLaw LLP Investigates Apex Technology Acquisition Corporation

·2 min read

NEW YORK, Nov. 24, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apex Technology Acquisition Corporation ("APXT" or the "Company") (NASDAQ: APXT) in connection with the Company's proposed merger with AvePoint Inc. ("AvePoint"), a privately held data management firm. Under the terms of the merger agreement, APXT will acquire AvePoint through a reverse merger that will result in AvePoint becoming a public company traded on the Nasdaq Capital Market under the new ticker symbol "AVPT." The transaction values the combined company at an equity value of approximately $2 billion.

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)
WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own APXT shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

Or please contact:
Joshua Rubin, Esq.

WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771

WeissLaw is investigating whether APXT's board acted in the best interest of APXT's public stockholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of AvePoint, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to APXT's public stockholders.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at


View original content to download multimedia: